Cyclofin contains two active ingredients: 200 mg/ml of the anti-inflammatory flunixin-meglumine (eq. to 33.2 mg/ml flunixin meglumine) and 300 mg/ml of the class D anti-infective, oxytetracycline (eq. to 323.5 mg/ml oxytetracycline trihydrate).
Dechra says Cylofin acts within 24-36 hours and has sustained anti-bacterial activity for five to six days following a single intramuscular injection.
Administration is deep intramuscular injection in cattle and Cyclofin has a 35-day withdrawal period and a memorable dose rate of 1 ml per 10 kg body weight.
Alana McGlade MRCVS, national sales manager at Dechra, said: “BRD is one of the most prevalent and costly diseases on farm and early administration of an effective and fast-acting NSAID/antibiotic combination treatment, such as Cyclofin, can help relieve discomfort and stress, alleviate pain and improve demeanour and food intake.”
Cyclofin is available in 100ml vials.
https://www.dechra.co.uk/products/livestock/prescription/cyclofin#Cyclofin-300mg-ml.
Guillaume Fournié and Dr Javier Guitian from the Royal Veterinary College - working with colleagues from the London School of Hygiene and Tropical Medicine and Imperial College - have developed a model to understand how live bird markets act as a "hub" of infection for domestic poultry and if rest days, during which such markets are emptied and disinfected, may reduce transmission.
The results are published today in Interface - the Journal of The Royal Society. PhD student Guillaume Fournié, who led the research, said: "Live bird markets can be a reservoir of infection for domestic poultry and may therefore be responsible for sustaining H5N1 HPAI virus circulation.
"Compared to interventions applied in farms - such as stamping out and vaccination - our model shows that frequent rest days are an effective means with which to reduce H5N1 HPAI infection rates. Furthermore, our model predicts that full market closure - as has been implemented in some countries such as Egypt and Vietnam - would only be slightly more effective than rest days to reduce transmission of the disease."
The models used in the study are based on the live bird market chain in Hong Kong and the analysis restricted to chickens. Fournié, who qualified to be a vet in Alfort in his native France, was awarded fully-funded studentships (tuition fees and a living allowance) in 2007 by The Bloomsbury Colleges - a consortium of six colleges of the University of London: Birkbeck, IoE, LSHTM, RVC, School of Oriental and African Studies, and The School of Pharmacy - to conduct the research.
Since December 2003 outbreaks of H5N1 Highly Pathogenic Avian Influenza (HPA1) affecting domestic poultry have been reported in 50 countries across the world. Massive economic losses and the pandemic threat make H5N1 HPAI one of the greatest current public health concerns.
A full copy of the report can be seen in Interface at http://rsif.royalsocietypublishing.org
Three new learning aids launched by BVA:
Practical Animal Handling - Online Tutorial The BVA AWF have launched an online tutorial on practical animal handling which has been prepared in conjunction with Newcastle University. The tutorial is primarily aimed at veterinary students and nurses. It features videos of expert veterinary staff demonstrating the correct procedures for handling small animals for clinical examination and medication and its aim is to show that the primary consideration should be for the welfare of the animal. To access the online tutorial visit http://www.bva-awf.org.uk/resources/tutorials/.
Disbudding of Kid Goats The Goat Veterinary Society (GVS) has produced a DVD designed to help veterinary surgeons to disbud goats. Produced in association with the BVA Animal Welfare Foundation the DVD is in memory of the late Mike Teale MRCVS, following a donation from his family. The DVD discusses the potential problems associated with disbudding kid goats and provides guidance on how to avoid them. It shows the best technique for disbudding from start to finish and discusses anatomical considerations, methods of anaesthesia and analgesia and disbudding, with particular attention drawn to the regulatory aspects as they currently apply in the UK. For further information on the GVS DVD, including obtaining a copy, at a cost of £10, please visit http://www.bva-awf.org.uk/headlines/news/Disbudding_of_kid_goats_DVD__2_.pdf.
Bat Care Guidelines - a Guide to Bat Care for RehabilitatorsThe Bat Conservation Trust (BCT) has produced Bat Care Guidelines, in association with the BVA AWF, RSPCA and RCVS Trust, aimed at veterinary professionals, wildlife hospitals and new rehabilitators. The document is split into basic sections including 'health and safety', 'rescue and collection' and 'ailments and treatments' which aim to provide minimum guidelines for bat care. The new initiative is part of an ongoing partnership focusing on the rehabilitation of wild bats in the UK. Visit http://www.bva-awf.org.uk/grants/projects/BCT_workshop_article_08.pdf for further information
The research will specifically focus on Mycoplasma hyopneumoniae (M.hyop), the causative agent of the disease, and aim to progress vaccine development.
Zoetis has stumped up another £300K in kind to support the research.
M.hyop is present in 80% of UK pig herds, which can result in a 16% reduction of growth and a 14% reduction in feed conversion in pigs.
This therefore, is not only a welfare issue for pigs but can significantly increase production costs for farmers.
Piglets are at particular risk of contracting the disease alongside secondary pathogens during lactation.
There are currently no commercial vaccines available that would prevent initial infection, and while M.hyop is susceptible to a variety of antibiotics, their use needs to be reduced to avoid overuse and the occurrence of multi-drug resistant strains.
The priority for the RVC researchers will therefore be developing new vaccines.
The team will also research the optimisation of protocols to eliminate M.hyop from pig herds in an effort to further minimise potential transmission.
Professor Dirk Werling, Professor of Molecular Immunology at the RVC, said: “Infection of Mycoplasma hyopneumoniae is a really debilitating disease in pigs that causes huge economic losses for farmers.
"I am very pleased that we will be able to continue working with a pharmaceutical partner to develop a new vaccine using state-of the-art technologies.”
Hysolv Animal Health has announced that it is offering a free swine flu laboratory diagnostic service to veterinary surgeons in the UK and Ireland.
The company will supply kits to veterinary surgeons with which to take samples from pig herds they suspect are infected with swine flu. The samples, nasal swabs or blood, will be sent direct to Germany where vaccine and biological company IDT Biologika is using a special facility to detect which viruses or antibodies against certain serotypes are present.
The virological tests will be conducted by the Institute for Virus Diagnostics, part of the Federal Research Institute for Animal Health. Antibody titres against H1N1, H1N2, H3N2, panH1N1 and panH1N2 will be looked for. Hysolv says these tests, including histopathology, can provide the only conclusive proof of influenza infection.
Results from the test — which would normally cost 230 Euros (about £185) to conduct — will be available within a week. IDT is believed to be the first company offering this type of test.
According to the company, the PCR test — from nasal swabs — is much more precise than previous testing regimes and will identify and type circulating strains as well as emerging strains.
Hysolv says that when swine flu strikes a farm, the signs seen are no longer just typically flu-like but a show whole range including fever, coughing, dyspnoea as well as returns to oestrus and abortions in sows. These may be in combination and concurrent with other diseases which makes accurate diagnosis difficult.
IDT will be offering the newly-branded vaccine Respiporc Flu 3 where the veterinary surgeon feels vaccination in indicated.
Hysolv director Richard Brealey said: “IDT is raising the bar in flu testing and this is a significant advance on what has been done in the past. In 2014 one-third of 1353 nasal swabs sent for testing proved positive for swine flu in Germany. In the UK the samples will help give an insight into the epidemiological status quo of the national pig herd.”
US-based Life Technologies has launched a new PCR-based test system which, according to the company, allows large numbers of pigs to be screened more quickly and cost-effectively for a range of common pathogens, such as PRRSV, SIV and PCV2.
The system uses samples of oral fluids which can be obtained by leaving a cotton rope in each pen for pigs to chew on. After 20 minutes or so, the rope can be retrieved and the saliva and gingival crevicular fluid squeezed into a sample bag and represents a pooled sample from the group.
Studies have demonstrated that oral fluid samples collected in this way can form the basis of a quick and cost-effective method for screening a range of common viral pathogens. The samples were tested using a commercially available sample preparation and real-time PCR test system which can isolate and identify viral nucleic acid in a matter of hours.
For PRRS, pooled samples of oral fluids were collected from groups of experimentally infected pigs using the rope technique, along with serum samples from each individual pig on the same days. Both serum samples and oral fluids were processed using the same Applied Biosystems preparation system and real- time PCR test, both of which were supplied by Life Technologies. The results showed that PRRSV nucleic acid was detectable in both serum and oral fluid samples from the day of infection through to 40 days after infection.
For PCV2, 24 pigs that were free of PRRSV and SIV were divided into 4 pens in separate rooms, and challenged with two different virus strains (PCV2a and PVC2b) at different times. One pen acted as a (non-challenged) control. Oral fluids were collected regularly up to 140 days after initial challenge and tested using real-time PCR. High titres of PCV2 were detected from day 12 to day 28 post infection and virus was detectable throughout the entire testing period (days 2 to 98).
For SIV, a total of 180 spiked oral fluid samples were tested using real-time PCR, and subtyping reagents were also used to identify haemagglutinin and neuraminidase subtypes. The results showed that SIV nucleic acid was detectable in oral fluid samples spiked with high, medium and low copy numbers of SIV, and all positive samples could be successfully sub-typed.
Christina Boss, European Professional Service Veterinarian for Life Technologies said: "Collecting samples in this way is far less invasive for the pigs and so avoids unnecessary stress. And because all of the pigs will chew on the rope, it provides a very broad sample from the group, which is the key to assessing overall herd health. In addition, if the pooled sample provides a positive result, then the animals in that pen can be tested individually to identify those that are infected.
"These results show that the simplicity of oral fluid sampling, combined with the speed and sensitivity of a PCR-based system, provides a practical and cost- effective way of monitoring large numbers of pigs for common virus pathogens.
"The use of a semi-automated, PCR-based diagnostic system means that nucleic acid purification can be achieved in just 25 minutes and results from the real-time PCR available in 90 minutes. The molecular test is very specific and reliable, so the veterinarian can initiate individual testing as quickly as possible and make confident recommendations to the producer."
According to Life Technologies, screening for PRRS using samples of oral fluids has been gaining popularity over recent years because large numbers of pigs can be tested without increased cost or labour. The new research is due to be presented as a poster at the ESPHM meeting in Bruges in April.
Novartis Animal Health UK has announced that it is committed to maintaining a reliable supply of Bovidec BVD virus vaccine throughout the coming season.
The announcement comes following concerns surrounding the availability of BVD vaccines. Novartis Brand Manager Eugene Smyth said: "We have been in discussion with the regulatory authorities to try and ensure we can meet the demand over the coming months and we have a large team of territory managers and technical services veterinarians dedicated to supporting our customers through the season".
Bovidec BVD virus vaccine, immunises adult cattle against the BVD Type 1 virus and for active immunisation of calves against BVD Type II virus.
BCF Technology has announced the launch of its new BUG ultrasound goggles. The company says that by using cutting-edge OLED display technology, BUGs deliver significant improvements in viewing images from fertility and pregnancy scanning of cattle, sheep, deer and goats.
BCF also says that BUGs are rugged and reliable, combining unprecedented display performance with excellent peripheral vision, and set a new standard in viewing ultrasound images. Optimised for grey scale imaging, the binocular style viewing features a full resolution display on which every ultrasound pixel is displayed. They are headband mounted for comfort and tough enough to suit any environment.
Gavin Mitchell, BCF’s Sales Director, said: “We spent over a year researching the needs of vets and developing the optimum technology for BUGs. We understand the problems that vets have experienced with monocular and binocular goggles, and we have successfully developed the ultimate solution for ultrasound scanning.”
Andrew Bronson, Cattle Vet, Alberta, Canada, said; "These durable goggles give me great peripheral vision when scanning cattle, which means that scanning is a lot safer. With the larger field of view and improved image quality over monocular goggles, I’ve finally found a permanent solution for portable ultrasound."
Charles Marwood, BVM & S, MRCVS, Clyde Veterinary Group, Scotland, said: "These goggles give a crisp, superior image and a fantastic resolution. They are very comfortable to wear with no safety issues."
BUGs are designed specifically for use with the BCF Easi-Scan ultrasound scanner. For more information, visit: http://www.bcftechnology.com/
Janssen Animal Health has released the results of a survey which suggests incorrect worming strategies on many pig units in the UK are costing the industry dearly.
Most state they do not worm weaners, growers or finishing pigs at all and, while most sows are wormed, only a third treat newly-arrived gilts and boars in quarantine.
Phil Macdonald, UK and Ireland pig business manager at Janssen said: "Worm infestations can harm growth rate and feed efficiency, they can reduce abattoir returns and increase the cost of medication".
According to the company, the survey responses point to confusion among some producers on what constitutes a strategic worming programme. Most, 68 per cent, state they have implemented strategic programmes, but fewer than two-thirds of these cover all pigs on a unit and even fewer correctly base their programmes on the pre-patent period of worms.
Phil said: "It's important that all pigs on a unit are covered by the programme, otherwise there is a higher potential for reinfection. To be effective, the anthelmintic treatment periods need to be based on the pre-patent period of worms, so that treatment interrupts their life cycle.
"It requires a strategic worming programme with a broad spectrum anthelmintic such as Flubenol and Solubenol 100mg/g, which is the first and only water-soluble benzimidazole in the market. These are effective against larvae and worm eggs of a number of worm species as well as the large roundworm, Ascaris suum. Migrating larvae of the large roundworm cause Milk Spot lesions in pig livers, which are damaging to animal welfare and unit economics."
The make-up of UK units in the survey was 58 per cent breeder/finisher, 39 per cent finisher, 3 per cent weaner/finisher. Most, 68 per cent, use dry pelleted feed, 16 per cent wet feed and 16 per cent have both feed systems.
There is wide variation in worming programmes among producers. Most breeders worm their sows - 17 per cent once a year, 56 per cent twice and 11 per cent three times. With boars, 28 per cent worm them once a year, 44 per cent twice and 11 per cent three times. But only one-third (34 per cent) of breeders worm newly-arrived gilts and boars in quarantine.
72 per cent of producers with breeding sows who responded do not worm weaners and 80 per cent do not worm growers. Of the total responses, including specialist finishers, 68 per cent do not worm finishing pigs.
Most producers, 81 per cent, stated that they are aware that livers with Milk Spot lesions have to be trimmed or totally condemned, adding significant annual costs for disposal.
68 per cent admit to Milk Spot lesion levels of 25 per cent in consignments of pigs. Another 10 per cent experience up to 75 per cent livers with Milk Spot damage, and 3 per cent have had every pig liver in a consignment trimmed or condemned because of lesions. The feedback to producers comes from the BPEX Pig Health Scheme, of which 88 per cent of producers are members.
Only 58 per cent of producers are aware that more traditional worming methods allow pigs continuously to reinfect each other and their environment. Traditional programmes do not take the worm's life cycle into account.
The detrimental effect of worm damage that causes most concern to producers is lost growth/poorer feed conversion (29 per cent). Others considered the most important to be:
Phil says research shows that losses in daily liveweight gain alone add up to £2.31 per slaughter pig where liver condemnations are 30 per cent. "The frightening fact is that the loss is for every slaughter pig, not just those with Milk Spot lesions.
"In a 300-sow herd producing 23 pigs per sow per year that's a loss of £15,939 a year. On a 1,000-sow unit that exceeds a horrendous £53,000 annually, and these figures take no account of other areas of loss mentioned."
An adult female worm can shed hundreds of thousands of eggs each day, which pigs pass out in their dung. Worm eggs can remain infective for up to 10 years. Other pigs ingest them and the reinfection process begins.
Phil said: "A strategic worming programme that treats all pigs on a unit simultaneously is the only effective way to almost completely eliminate the problem. The survey has shown there is considerable potential for a large proportion of producers to improve productivity and cut costs by focusing on this critical area of management."
Following stock challenges earlier in the year, the company is now urging vets to encourage farmers to vaccinate their flocks to prevent abortions during lambing.
Roy Geary, regional director for Northern Europe at Ceva Animal Health, said: “While we realise that the temporary delay of Cevac Chlamydia has been inconvenient to our valued sheep farmers we would like to thank all our customers for their patience and support during this challenging time.
"The vaccine supply is now available in the UK for the latter end of the season.
"Farmers tupping later in October should therefore be encouraged to vaccinate their flocks to protect their ewes from this devastating disease.”
www.enzooticabortion.co.uk
The Veterinary Laboratories Agency has worked in collaboration with the Institute of Animal Health (IAH) at Pirbright to introduce the Polymerase Chain Reaction (PCR) test for Bluetongue virus.
This test is now available via veterinary surgeons for pre-movement (UK) and export testing purposes only.
As of this date, PCR testing for these purposes will no longer be available from IAH, Pirbright.
For further information see www.vla.gov.uk
.
Zoetis has released new surveillance results which show that Mycoplasma bovis is becoming an increasingly significant pneumonia pathogen in cattle1.
In more than 2,500 samples submitted by vets for analysis during 2014, 45% were positive, compared with 41% in 2013.
According to Dr Tim Potter MRCVS from Westpoint Veterinary Group, Mycoplasma bovis has emerged as an important pathogen of calves worldwide2. He said: "It is associated with a number of clinical presentations including respiratory disease, otitis media and arthritis.
"The role of Mycoplasma bovis in pneumonia is well established and there are a number of reports in the literature of respiratory disease outbreaks where it was the predominant bacterium isolated. However, as with most causes of pneumonia, colonisation by Mycoplasma bovis alone is not always sufficient to cause disease and it may present in combination with other respiratory pathogens."
For other pathogens, the surveillance found 83% of samples positive for Para-influenza 3 virus (Pi3v), 76% Bovine Respiratory Syncytial virus (BRSv), 32% IBR, and 25% for BVD. Apart from BVD, which saw a three-point reduction from 28% the previous year - these show little change from 2013.
According to Zoetis vet Carolyn Hogan, in pneumonia outbreaks involving Mycoplasma bovis, many of the clinical signs are similar to those caused by other pneumonia pathogens: coughing, raised temperature, rapid breathing and lethargy.
She said: "This can make it difficult for farmers and vets alike to identify Mycoplasma bovis as a possible cause of disease based on clinical signs alone, unless calves are also showing some of the other distinguishing signs associated with Mycoplasma infection.
"These include ear infections, head shaking or tilting, and arthritis. Poor response to treatment, with resulting chronic respiratory cases, may also be suggestive of Mycoplasma infection. For a definitive diagnosis, of course, analysis of blood or respiratory tract mucous is required."
Whilst vaccination protection is available against the viruses (BRSv, Pi3v, BVD and IBR) and Mannheimia (Pasteurella) haemolytica, Carolyn points out that there is no ‘off the shelf’ vaccine available for Mycoplasma bovis. She adds that treatment can be challenging due to the insidious nature of disease, and lack of effectiveness of some antibiotics.
Once Mycoplasma bovis is present on a farm, Carolyn cautions that eradication can be very difficult. "It can be transmitted in milk from carrier cows, and in saliva among calves, particularly when multiple animals suckle the same teat feeders.
"Minimising this pathogen's impact on health and productivity relies on reducing its exposure to susceptible animals and maximising their resilience against it. For a comprehensive programme of control measures, farmers should consult their vet."
Carolyn suggests that such a programme is likely to include: testing the farm's Mycoplasma bovis status; effective biosecurity; not feeding infected milk; ample ventilation for adults and youngstock alike; rapid spotting of sick animals, isolation and vet-prescribed treatment; vigilance for poor response to treatment and development of chronic cases; vaccination against main viral pneumonia pathogens; and low stress through good stockmanship.
References
Photo: By Y tambe (Y tambe's file) [GFDL, CC-BY-SA-3.0 or CC BY-SA 2.5-2.0-1.0], via Wikimedia Commons
The collaborative study, which was sponsored by Norbrook, involved each practice blood testing a cohort of six lambs on 25 individual farms from 16 weeks of age, to look for evidence of antibodies to liver fluke.
Only 11 farms had positive results in the period from June, up to December, with most only showing one or two lambs out of the six sero-converting later in the year. Even farms located reasonably close by showed positive cases months apart.
Mark Thompson of Craven Farm Vets in Yorkshire said, “I did not expect to see positive results as late in the year. I expected a positive result earlier (September/October) as the farm is a very wet farm with a long-standing issue with fluke. Also, the weather in the area has been ideal for the intermediate host and fluke development on the pasture.”
Emily Baxter of Drove Farm Vets in Wiltshire said she thinks there is scope to use the results to improve the timing of dosing with flukicides and more responsible use: “We will use the results from this year’s testing to re-evaluate the farm’s fluke control protocol which will help reduce the level of use of flukicides earlier in the season for years with similar weather patterns and assist in planning of strategic grazing.
"We’re looking forward to continuing our work this year, no two years are ever the same, that’s why monitoring is so important. It will allow both ourselves and our clients to build up a picture over time of what’s happening not only on their individual farms, but potentially down to field level! This will allow us to provide more conclusive recommendations. For now, it’s clear that testing has great promise as a means to provide tailored advice to farms on how to control fluke and use the flukicides available to us responsibly.”
Emily says it’s important that farmers do not stop using flukicides based on the results of this study nor assume that there is less risk: “We all know how significant the losses from acute and chronic fascioliasis can be. We therefore encourage farmers to talk to their vet before they change their flukicide treatment protocols and discuss the possibility of using serology as an adjunct to determine how and when they treat.”
Veterinary professionals can find out more about the fluke sentinel project at https://xlvets-farm.co.uk/fluke-sentinel or the XLVets community at https://www.xlvets.co.uk/the-boss/.
Scientists at the Royal Veterinary College, contributing to a programme to tackle some of the most harmful and widespread endemic diseases that commonly affect farmed animals in the UK, have developed a severity estimation calculator for post-weaning multi-systemic wasting syndrome (PMWS).
Post-weaning multi-systemic wasting syndrome (PMWS) is a common disease of young pigs in the U.K. It is extremely debilitating, causes considerable suffering and poor welfare, and has a high mortality of up to 30%. It is estimated that the disease costs the UK farming industry £30m per year.
The £2.4m project - headed by Professor Dirk Werling from the Royal Veterinary College and funded by the Biotechnology and Biological Sciences Research Council (BBSRC) through its "Combating Endemic Diseases For Farm-Animal Sustainability" programme (CEDFAS), the British Pig Executive (BPEX), and two industrial partners, Pfizer Ltd (UK) and BioBest - aims to identify why PMWS occurs and to develop new methods of controlling the disease.
One key-component of the project is the direct involvement of British pig farmers, thereby guaranteeing that pigs in Britain will be the first to benefit from this research, while collaboration with a major international pharmaceutical company will ensure that new veterinary products will be made available to pig farmers worldwide.
Now, two members of the team, Dr. Barbara Wieland and Pablo Alarcon-Lopez, a second year PhD student, have developed a novel approach to quantify severity of PMWS based on morbidity and mortality data and presence of porcine circovirus type 2 (PCV2). They applied factorial analyses, using data collected from 147 pig farms in England to identify variables contributing to variation in PMWS severity in a biologically meaningful way.
Together with other known variables linked to PMWS, the resulting factors were used to derive an algorithm for PMWS severity. The derived algorithm was used to develop a PMWS severity calculator, which now can be used by farmers directly to assess the PMWS severity on their own farm (http://www.bpex.org.uk/articles/300874).
The levels of PMWS severities identified on farm level can now be used to identify risk factors related to the different severity-categories, to assess the efficacy of PCV2 vaccination and to investigate the economic impact of potential control measures on a farm.
Nominated by a colleague, Will graduated and joined the practice in 2021, having previously worked as a dairy herdsperson.
In his nomination, clients described Will as having an excellent understanding of the practicalities of running a herd, and said he provides realistic and achievable advice.
The judging panel was impressed by Will’s dedication to improving health, welfare, and productivity on dairy farms with his clear advice and workable action plans.
In addition, Will set up an embryo transfer service, bringing a new service to his practice, along with a robot discussion group, all of which have made a significant and positive impact to his dairy farming clients.
Will said: “It was a real privilege to be awarded the Young Dairy Vet of the Year award amongst so many talented and dedicated farm vets in our line of work.
"Above all it is a testimony to the farmers I work with day to day and the proactive attitude they take to improving their systems which has given me so many opportunities to develop my career”.
This year’s runner up was Hana Ward of Torch Vets in Barnstaple, Devon.
Photo: Will with last year's winner, Tom Warboys.
The RCVS has brought out a new publication to help members of the veterinary and veterinary nursing professions understand their legal and professional obligations regarding controlled drugs.
Controlled Drugs Guidance is a consolidation of existing advice and guidance on controlled drugs from a number of organisations including the RCVS itself, the Veterinary Medicines Directorate (VMD), the British Small Animal Veterinary Association (BSAVA) and the Home Office. The guide also gives details of the existing legislation concerning controlled drugs, namely the Misuse of Drugs Act and associated regulations.
The guidance provides advice on a variety of topics to reflect the common queries the RCVS Advice Team receives, such as storage, destruction and disposal; keys and keyholders for controlled drugs cabinets; controlled drugs in vehicles; and veterinary nurses administering controlled drugs.
The publication also deals with specific controlled drugs such as ketamine which, on 30 November 2015, was rescheduled to a Schedule 2 controlled drug, meaning that it is now subject to the same strict storage, prescription, dispending, destruction and record-keeping requirements as other medicines in this Schedule.
Laura McClintock, Standards and Advisory Manager at the RCVS, said: “We hope that this publication will help members of the profession navigate the often complex legislative and professional requirements regarding controlled drugs, as well as imparting best practice advice on how they should be stored and disposed and so on.
"This publication has also been endorsed by our colleagues in the Home Office, VMD and BSAVA and, because this is an area that is subject to regular change, we will make sure to keep it up-to-date as and when the regulations change."
The publication is available to download from the RCVS website at www.rcvs.org.uk/publications
As the House of Lords begins its debate on the religious slaughter of farm animals, the RSPCA is calling for all to be pre-stunned.
More than 900 million farm animals are slaughtered for meat in the UK every year. The vast majority are stunned pre-slaughter. However, the law permits the Jewish and Muslim communities to kill animals by religious methods without any form of pre-stunning.
The RSPCA says that while it recognises that religious beliefs and practices should be respected, it also believes that animals should only be slaughtered under the most humane conditions.
RSPCA Dr Julia Wrathall, head of the RSPCA's farm animal science department said: "Farm animals deserve to be treated with care and respect throughout their lives, from the time they are born right up to their final moments in the abattoir.
"We want to see all animals rendered unconscious before slaughter. Until that time we are calling for clear labelling so shoppers are armed with information that can enable them to make an informed choice about whether they buy meat from animals which have not been stunned before slaughter.
"Until there is better, universal labelling, shoppers should look for the blue and white Freedom Food label. Meat produced under this RSPCA assurance scheme comes from animals inspected to the RSPCA's farm animal welfare standards which do not permit slaughter without pre-stunning."
According to the charity, scientific research shows that slaughtering animals without pre-stunning (to render them insensible to pain and distress) can cause unnecessary suffering.
David Bowles, head of public affairs for the RSPCA, who has written a report for the House of Lords debate, added: "We know this is a subject that our supporters feel passionately about. We share their welfare concerns and that is why we have continued to campaign for religious slaughter to be discussed at the highest possible levels."
The RSPCA works with the Food Standards Agency (FSA) to publish the results of the FSA's Animal Welfare Survey undertaken in abattoirs across Great Britain.
The latest survey* results shows:
The RSPCA believes mandatory labelling should be introduced so that all meat that has not been stunned is labelled and says it will press for European rules on this in 2014.
Virbac Animal Health has launched a special scheme to encourage farmers to have milk samples analysed in line with the industry-wide campaign to promote the responsible use of antimicrobials.
Under the terms of the scheme, veterinary surgeons purchasing Virbac's Cephaguard DC therapy will receive vouchers to distribute to their farmer clients. These vouchers can be redeemed for milk bacteriology to determine the pathogens causing mastitis and so ensure treatment is more targeted and effective.
Brigitte Goasduf MRCVS, Ruminants Marketing Manager at Virbac, said: "Mastitis is a major concern for dairy farmers with reported numbers of cases ranging from 26-50 for every 100 cows.
"Experts agree that individual SCC monitoring and the accurate diagnosis of pathogens causing infection are key to treating mastitis effectively. Unfortunately many farmers are often deterred by the cost.
"Our scheme gives our veterinary customers the opportunity to foster good practice by encouraging farmer clients to submit milk samples for investigation at no cost to them. This will then enable them to treat the bacteria causing the infection in line with industry guidelines for the use of antimicrobials.
"Over time, we believe farmers will come to realise that adopting this more targeted approach is not only more cost-effective but will also preserve their ability to treat their herd, both now and in the future."
For further information on the scheme, contact your Virbac territory manager or call Virbac on 01359 243243.
The British Occupational Hygiene Society (BOHS) has announced the publication of a book on controlling skin exposure and wet work. The book aims to fill a knowledge gap about dermal exposure risk management in workplaces which are particularly affected, such as veterinary practices.
The consequences of a failure to adequately control dermal exposure to hazardous agents do not always become apparent until years after exposure, and because of this, many employers are either ignorant of the consequences or ignore the potential for ill-health until it is too late. In Great Britain, over 29,000 people are suffering from work-related skin disease and every year over 3,500 new cases are reported. Alongside this, many workers are unaware of the ways in which skin comes into contact with chemicals, or how dermal exposure can contribute to inadvertent inhalation and ingestion exposure.
Healthcare workers are susceptible. Vets and nurses are, for example, at risk from disinfectants, detergents, wet-work, latex gloves, anaesthetics, antibiotics and antiseptics, phenothiazines, formaldehyde, glutaraldehyde and liquid chloroxylenol.
The book provides an introduction to the structure and functions of the skin, information about the diseases caused by dermal exposure and the occupations and chemicals involved, regulatory requirements related to dermal exposure at work, exposure and risk assessment, and risk management strategies. It is both comprehensive and accessible, and clearly illustrated with photographs, figures and tables throughout, ensuring that it will be of practical use. As a result, BOHS believes that it will make an important contribution to increasing knowledge about control of dermal exposure, and encourage more effective control measures to be introduced in workplaces.
‘Controlling Skin Exposure to Chemicals and Wet-Work' is available for £19.99 and can be purchased on-line via RMS Publishing, www.rmspublishing.co.uk/BOHS.html and Amazon, or by posting/faxing the order form which can be downloaded from the Publications section of the BOHS website.
The new award, sponsored by Krka UK, will recognise an exceptional farm vet who has been working in the dairy industry for three to five years and who has contributed significantly to the health and wellbeing of herds under their care.
Sarah Tomlinson, veterinary surgeon at Westpoint Farm Vets in Derbyshire, Technical Director of the TB Advisory Service (TBAS) and recipient of the 2020 Dairy Vet of the Year, said: “In recognising achievement among more recently qualified vets with this new award, Krka is giving the boost every young vet needs to shake off the ‘new grad’ title and instead become an ‘high performing’ vet, judged by their industry peers to be one of the best. Many vets can suffer with imposter syndrome so it is important that we accept positive acknowledgement of our work and our everyday achievements so that we can be rightly proud of what we do.”
More information about the CREAM Awards and the nomination process can be found here: https://www.britishdairying.co.uk/cream-awards-2021/
BCF has launched the Easi-Scan remote display, designed for on-farm use.
The company says the Easi-Scan offers unprecedented display performance, is very portable (weighing less than 2Kg) and very rugged. According to the company, Its 8.4" transflective LCD screen provides excellent quality images for fertility and pregnancy scanning meaning it can be used as the sole display for BCF's Easi-Scan and Duo-Scan ultrasound scanners. And with a dedicated channel button, you can switch between all available ultrasound channels, allowing you to view a number of examinations at once.
The Easi-Scan is also available with a Gorilla pod allowing it to be attached to railings and a carry strap.
Gavin Mitchell from BCF said: "At BCF innovation is key; we have invested a lot of time developing a remote display monitor that is well suited to the needs of the market. Through listening to our customers, we feel we have successfully achieved this. It is ideal for training purposes and viewing multiple exams. It is also the only wireless and splashproof remote ultrasound display on the market."
For more information call 01506 460023 or visit http://www.bcftechnology.com/.